Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)
CNY 38.25
(-0.52%)
CNY 38.25
(-0.52%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 106.6 Million CNY | -86.22% |
| 2022 | 773.63 Million CNY | -7.19% |
| 2021 | 833.59 Million CNY | 91.57% |
| 2020 | 435.14 Million CNY | 1441.52% |
| 2019 | 28.22 Million CNY | 49.3% |
| 2018 | 18.9 Million CNY | 369.01% |
| 2017 | 4.03 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 32.54 Million CNY | -17.88% |
| 2024 Q3 | 17.03 Million CNY | -47.65% |
| 2024 Q1 | 39.63 Million CNY | 162.84% |
| 2023 Q2 | 49.7 Million CNY | 317.7% |
| 2023 FY | 106.6 Million CNY | -86.22% |
| 2023 Q4 | 15.07 Million CNY | -49.61% |
| 2023 Q3 | 29.92 Million CNY | -39.79% |
| 2023 Q1 | 11.89 Million CNY | 110.64% |
| 2022 Q3 | 139.82 Million CNY | -44.61% |
| 2022 Q1 | 492.52 Million CNY | 330.23% |
| 2022 Q2 | 252.43 Million CNY | -48.75% |
| 2022 FY | 773.63 Million CNY | -7.19% |
| 2022 Q4 | -111.84 Million CNY | -179.99% |
| 2021 FY | 833.59 Million CNY | 91.57% |
| 2021 Q4 | 114.48 Million CNY | -23.87% |
| 2021 Q3 | 150.37 Million CNY | -55.19% |
| 2021 Q2 | 335.57 Million CNY | 43.93% |
| 2021 Q1 | 233.15 Million CNY | 195.38% |
| 2020 FY | 435.14 Million CNY | 1441.52% |
| 2020 Q4 | 78.93 Million CNY | 46.93% |
| 2020 Q3 | 53.72 Million CNY | -79.85% |
| 2020 Q2 | 266.56 Million CNY | 641.84% |
| 2020 Q1 | 35.93 Million CNY | 0.0% |
| 2019 FY | 28.22 Million CNY | 49.3% |
| 2018 FY | 18.9 Million CNY | 369.01% |
| 2017 FY | 4.03 Million CNY | 0.0% |